Literature DB >> 25289351

A comparative analysis of 2 national breast reconstruction surveys: concerns regarding autologous and microsurgical breast reconstruction.

Raffi Gurunluoglu1, Michael Bronsert1.   

Abstract

BACKGROUND: Pertinent findings of two national breast reconstruction (BR) surveys from two different institutions at two separate times (2012 vs 2010) were analyzed for comparison.
METHODS: An appraisal of sampling methodology, sample demographics, years of practice, practice affiliation, BR type, and annual volume between the two studies was conducted using statistical analysis.
RESULTS: Proper sampling technique and adequate sample size were used in both surveys to represent the typical population of general US plastic surgeons practicing BR. There were no differences in mean age or years of practice between the sample population in both studies. The percentage of plastic surgeons with academic affiliation was higher in the 2012 survey compared to the 2010 survey (28% vs 18%, P<0.05). Implant-based BR was the predominant method among surveyed plastic surgeons in both surveys. There was a substantial decrease in the proportion of plastic surgeons performing >20 cases per year in the 2012 survey compared to the 2010 survey (P<0.05). A high volume of BR, defined as >60 cases per year in the 2010 survey and >20 cases per year in the 2012 survey, correlated significantly with academic practice and multidisciplinary cancer centers, respectively (P<0.05). There was a significant decline in the percentage of plastic surgeons performing microsurgical BR from 2010 to 2012 (35% vs 25%, P<0.05).
CONCLUSIONS: Comparative data suggest that there are fewer high volume BR cases being performed by US plastic surgeons and that there has been a reduction among plastic surgeons in the use of microsurgical BR from 2010 to 2012. We believe that these findings may indicate early signs of the changes in BR trends in the US.

Entities:  

Year:  2014        PMID: 25289351      PMCID: PMC4174087          DOI: 10.1097/GOX.0000000000000100

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


Survey studies using self-reported responses have provided satisfactory data to generate an overview of practice patterns in relation to various plastic surgery procedures.[1-6] Kulkarni et al[7] reported on a national survey of US plastic surgeons that investigated surgeon and practice characteristics with a special emphasis on autologous and microsurgical breast reconstruction (BR). The data obtained by the survey were presumably reflective of BR practices in 2012. In 2010, we performed a national survey of active members in the American Society of Plastic Surgeons (ASPS) to ascertain trends and practice patterns in BR.[8] A comparative analysis was conducted between 2 national surveys to capture similarities and notable changes regarding BR practice from 2010 to 2012.

METHODS

First, we noted that proper sampling technique and adequate sample size were used in these 2 surveys to allow appropriate statistical analysis. Second, we examined sample demographics, such as age, gender, and years of practice, of 2 surveys. There were no differences in mean age (t test, P = 0.95) or years of practice (chi-square test, P = 0.2) between both studies’ sample populations (Table 1).
Table 1.

Sample Demographics of 2 Surveys

Sample Demographics of 2 Surveys Finally, we analyzed the surveys regarding practice affiliation, BR type, and annual volume. However, we ensured that this comparative analysis was made to provide a meaningful perspective.

Statistical Analysis

An assessment of differences/similarities between the 2 survey studies was conducted using the t test for continuous variables and the chi-square test for categorical variables. Results were considered statistically significant when the P value is less than 0.05.

DISCUSSION

In the survey by Kulkarni et al,[7] a substantial decrease was noted in the proportion of plastic surgeons performing > 20 cases/year compared with the 2010 survey. There was also a discernible increase in the percentage of plastic surgeons performing 1–20 cases/year in the 2012 survey compared with the 2010 survey[8] (Table 2).
Table 2.

Data on Annual Breast Reconstruction Volume and Breast Reconstruction Technique Including Microsurgical Type in the 2 Surveys

Data on Annual Breast Reconstruction Volume and Breast Reconstruction Technique Including Microsurgical Type in the 2 Surveys The identified change may reflect a trend toward the reduction in the number of BR procedures. According to the ASPS data, there were 5% and 2% decreases in the number of BR procedures for 2012[9] compared with 2011[10] and 2010,[11] respectively. Decline in annual volume may also indicate that BR procedures are still not the dominant procedure. BR was the sixth reconstructive procedure according to 2011 and 2012 ASPS statistics.[9,10] In the study by Kulkarni et al,[7] the average response by procedure was 79% for tissue expander/implant-based reconstructions (Table 2). Surgeons with a low volume of BR (<5 cases/year) performed implant-based reconstruction (IBR) for more than 90% of their patients. The surgeons with the highest volume of breast cases (>20 cases/year) reported performing IBR for about 70% of their patients. In the 2010 survey,[8] 82.7% of plastic surgeons reported predominantly performing IBR irrespective of the volume of BR or practice setting. These findings were also in accordance with the National Surgical Quality Improvement Program[12] database and ASPS statistical data. Also, a study[13] demonstrated that the number of IBR increased 11% per year from 1998 to 2008. During the same period, it was also noted that the number of autologous reconstructions decreased 5% per year. The most recent 2012 ASPS data revealed that IBR comprised the vast majority (70.4%) of BR.[14] In addition, the ASPS statistical data reported a steady increase in the number and percentage of tissue expander/implant-based reconstructions from 2008 to 2012.[10,11,14-16] Advancements in implant technology, absence of additional donor-site morbidity, lesser downtime, invasiveness, and labor intensity have made this option more attractive for the past several years. The trend seems to be further substantiated by the use of acellular dermal matrix. which allows achievement of better results.[8] Financial considerations may also play a role in the national trend toward IBR. Hernandez-Boussard et al[13] investigated Medicare reimbursement for BR between 2000 and 2010. The reimbursement for IBR remained relatively unchanged, with a decrease of 4% over a 10-year time period, whereas the average reimbursement for autologous reconstruction decreased 17%. Alderman et al[17] displayed that autologous reconstructions have lower reimbursement per operating room hour compared with IBR. Kulkarni et al[7] identified reimbursements as primary barriers to autologous and microsurgical BR. Reimbursement patterns and rates are influenced by the American economy.[18] Plastic surgeons have seen a steady decline in fees for reconstructive procedures.[19] These financial disincentives may be contributing to the low use of labor-intensive autogenous tissue procedures. The more labor-intensive autologous BR seems undervalued despite its significant long-term satisfaction. A cost efficiency analysis of implants versus autologous reconstruction found that initial resource costs were lower for implants, but the 5-year total costs were higher.[20] Adoption of a reimbursement program based on long-term outcomes may improve utilization of autologous BR.[21] In the 2010 survey,[8] plastic surgeons in academic practice preferred IBR less frequently compared with their colleagues in other practice settings (Fig. 1). Furthermore, our previous study indicated that a high volume of BR cases (>60 cases/year) significantly correlated with academic practice.
Fig. 1.

Percentage of respondents who most often used tissue expander/implant breast reconstruction according to their practice setting. Academic practice: 63.1% vs multispecialty practice: 88.9%, solo practice: 88.2%, and plastic surgery group practice: 82.4% (P < 0.05). Reproduced with permission from Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg. 2013;70:103–110.

Percentage of respondents who most often used tissue expander/implant breast reconstruction according to their practice setting. Academic practice: 63.1% vs multispecialty practice: 88.9%, solo practice: 88.2%, and plastic surgery group practice: 82.4% (P < 0.05). Reproduced with permission from Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg. 2013;70:103–110. Kulkarni et al[7] also found that a high volume of autologous BR cases, defined as > 20 cases/year, was significantly associated with the practice affiliation to a multidisciplinary cancer center. The 2010 survey[8] also demonstrated that plastic surgeons in academic settings generally prefer autologous BR more frequently than those in other practice locations (Fig. 2).
Fig. 2.

Percentage of respondents who most often performed autologous breast reconstruction according to their practice setting. 33.8% in an academic setting vs 9.2% in solo practice, 11.1% in plastic surgery group practice, and 7.4% in multispecialty group (P < 0.05). Reproduced with permission from Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg. 2013;70:103–110.

Percentage of respondents who most often performed autologous breast reconstruction according to their practice setting. 33.8% in an academic setting vs 9.2% in solo practice, 11.1% in plastic surgery group practice, and 7.4% in multispecialty group (P < 0.05). Reproduced with permission from Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg. 2013;70:103–110. Kulkarni et al[7] demonstrated that only one-quarter of plastic surgeons reported performing microsurgical BR as part of their BR practice (Table 2). They observed that a higher annual volume of BR cases, involvement in resident training, cancer center affiliations, and surgeons with microvascular training were associated with the provision of microsurgical BR. In the 2010 survey,[8] 34% of plastic surgeons reported performing microsurgery for BR (Table 2). Despite the fact that percentage of plastic surgeons with academic affiliation was higher in the 2012 survey than in the 2010 survey, there was a significant decline in the percentage of plastic surgeons performing microsurgical BR from 2010 to 2012. Our goal was to generate a comparative overview. However, survey studies possess inherent limitations. Both surveys were subject to nonsampling error, including nonbias response, and respondent recall bias. In addition, data were derived from self-report.

CONCLUSIONS

This comparative analysis identified similarities between two national surveys particularly as they relate to respondent demographics and the most frequent type of BR performed by US plastic surgeons, ie, implant-based BR. Significant changes were also noted; data suggest that there are fewer high volume BR cases being performed by US plastic surgeons and that there has been a reduction among plastic surgeons in the use of microsurgical BR from 2010 to 2012. We believe that these findings provide meaningful information and may indicate early evidence of the changes in BR trends among US plastic surgeons.

ACKNOWLEDGMENT

We thank Kendra Keene for editing the article.
  15 in total

1.  Areola-sparing mastectomy with immediate breast reconstruction.

Authors:  Rache M Simmons; Scott T Hollenbeck; Gregory S Latrenta
Journal:  Ann Plast Surg       Date:  2003-12       Impact factor: 1.539

2.  The economics of plastic surgery practices: trends in income, procedure mix, and volume.

Authors:  Lloyd M Krieger; Gordon K Lee
Journal:  Plast Reconstr Surg       Date:  2004-07       Impact factor: 4.730

Review 3.  Reducing U.S. health care spending: is it realistic or even desirable?

Authors:  John G Hunter
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

4.  Use of autologous and microsurgical breast reconstruction by U.S. plastic surgeons.

Authors:  Anita R Kulkarni; Erika Davis Sears; Dunya M Atisha; Amy K Alderman
Journal:  Plast Reconstr Surg       Date:  2013-09       Impact factor: 4.730

5.  Trends in autologous fat grafting to the breast: a national survey of the american society of plastic surgeons.

Authors:  Russell E Kling; Babak J Mehrara; Andrea L Pusic; V Leroy Young; Keith M Hume; Catherine A Crotty; J Peter Rubin
Journal:  Plast Reconstr Surg       Date:  2013-07       Impact factor: 4.730

6.  National interdisciplinary rhinoplasty.

Authors:  Jeremy Warner; Karol Gutowski; Liat Shama; Benjamin Marcus
Journal:  Aesthet Surg J       Date:  2009 Jul-Aug       Impact factor: 4.283

7.  Patterns and correlates of postmastectomy breast reconstruction by U.S. Plastic surgeons: results from a national survey.

Authors:  Amy K Alderman; Dunya Atisha; Rachel Streu; Barbara Salem; Ashley Gay; Paul Abrahamse; Sarah T Hawley
Journal:  Plast Reconstr Surg       Date:  2011-05       Impact factor: 4.730

8.  Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010.

Authors:  Raffi Gurunluoglu; Aslin Gurunluoglu; Susan A Williams; Seth Tebockhorst
Journal:  Ann Plast Surg       Date:  2013-01       Impact factor: 1.539

9.  Financial impact of breast reconstruction on an academic surgical practice.

Authors:  Amy K Alderman; Amy F Storey; Nita S Nair; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2009-05       Impact factor: 4.730

10.  Breast reduction trend among plastic surgeons: a national survey.

Authors:  Stanley A Okoro; Constance Barone; Mary Bohnenblust; Howard T Wang
Journal:  Plast Reconstr Surg       Date:  2008-11       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.